Partner of Garfinkle, Biderman LLP
Specialized in complex corporate transactions and corporate securities.
LL.N. cum laude and a Quebec Civil Law degree, both from the University of Ottawa.
Larry Latowsky
CEO
Former President and CEO of Drug Trading which included a network of over 1500 independent drug stores including IDA and Guardian.
Former President and CEO of Katz Group Canada
A wealth of experience and connections in the Canadian Pharmaceutical Industry
Barry M. Polisuk
Chairman
Founder of First Republic Capital
Co-Founder Fraser McKenzie, former EVP and Head of IB at Standard Securities
With 28 years of experience in Investment Banking, Research, Sales and Trading
MBA in Finance from McMaster University
Eric Malinski
Director of Marketing
Former President/CEO of Orbus Pharma
Business Development for Indukern Chemie AG
Extensive experience in drug formulation and business development
Richard Goldstein
Co-Founder & CFO
Education in marketing, and the neuropsychology of attention from the University of Toronto
Experience as the Director of Marketing at one of Mississauga’s largest real estate brokerages
Jeff Renwick
Head of Production
Vice President and Treasurer of Rompsen Investment Corp. and former Audit Committee Chair of Enwave Energy Corp.
Audit Committee Chair of Mission Ready Services.
MBA, CPA – CGA and member of The Institute of Corporate Directors.
Vitor Fonseca
Audit Committee
Compounding pharmacist for over ten years.
Passionate about the development of customized cannabis-based medications tailored to the needs of patients.
Erin Kofman
Pharmacist
Pharmaceutical Scientist with a successful history of bringing to market a number of pharmaceutical drugs throughout a career spanning 25 years.
Joshi Laxminarayan
Chief Scientific Officer
President of BLM Marketing Management.
Over 20 years of pharmaceutical executive experience with a successful track record in business development.
An expert in licensing strategies, both in Canada and international markets.
Bob Woloschuk
Advisory Board
Vice President, The Clinical Research Association of Canada.
President, Canadian Institute for Medical Advancement.
20 years of experience in clinical trials, including 7 studies on Cannabinoids, establishing her as a leader in the field.
Sabrina Ramkellawan
Advisory Board
Experience on the boards of several publicly traded cannabis companies, including Hiku Brands Company.
Developed a global network of contacts in the cannabis industry.
Lorne Gertner
Advisory Board
Founding COO of Bedrocan Canada, which was acquired by Tweed, now Canopy, delivering over $400 million in shareholder returns.
Responsible for the first legal transfer of live cannabis plant material from Holland to Canada.
A professional engineer with an MBA from Schulich.
Hamish Sutherland
Advisory Board
Former Chief Resident, Mt. Sinai Hospital, Toronto.
Former Family Physician to the Saudi Royal Family.
Founder, Regal Health Services
Dr. Eric Hatashita
Advisory Board